During the past decade, International Medical Center of Japan conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "International Medical Center of Japan" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Haruhiko Fukuda" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Japan Clinical Oncology Group" with 2 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "International Medical Center of Japan" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 5 trials as a collaborator, "Community Programs for Clinical Research on AIDS" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "International Medical Center of Japan" are "Diabetes Mellitus, Type 2" (2 trials), "Gastric Neoplasm" (2 trials), "HIV Infections" (2 trials), "Advanced Solid Tumors or Triple-negative Breast Cancer" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "International Medical Center of Japan" in a lesser frequency.

Most popular intervention types in "International Medical Center of Japan" are "Drug" (11 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Abemaciclib" (1 trials), "Empagliflozin" (1 trials), "Etoposide and cisplatin after chemoradiotherapy" (1 trials) and "Gastrectomy with more than D2 dissection" (1 trials). Other intervention names were less common.

The vast majority of trials in "International Medical Center of Japan" are 14 trials for "All" genders.

Currently, there are NaN active trials in "International Medical Center of Japan". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in International Medical Center of Japan, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in International Medical Center of Japan, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".